Thursday, November 14, 2024

Verastem shares surge more than 50% after pancreatic-cancer treatment study data

Must read



Shares of Verastem rose late Thursday after interim data from the company’s trial evaluating a combination therapies to treat pancreatic cancer showed a high overall response rate.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article